ANDA 74699, held by Watson Labs. Acetaminophen; Pentazocine Hydrochloride.
As of Nov 16, 2026, ANDA 74699 (Acetaminophen And Pentazocine Hydrochloride), held by Watson Labs, was first approved by FDA on Mar 24, 2000, with 4 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 24, 2000 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Acetaminophen And Pentazocine Hydrochloride650MG;EQ 25MG BASE · tablet;oral | Acetaminophen; Pentazocine Hydrochloride | Discontinued |
| Oct 18, 2013 | Supplement 22Labeling · Standard review | Approved | None posted |
| Aug 10, 2011 | Supplement 20Labeling | Approved | None posted |
| Apr 12, 2004 | Supplement 2Labeling | Approved | None posted |
| Apr 12, 2001 | Supplement 1Manufacturing | Approved | None posted |
| Mar 24, 2000 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters